|
|
Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma
Stephanie Guidez
,
Guillemette Fouquet
,
Helene Demarquette
,
Morgane Nudel
,
Eileen Boyle
et al.
Blood, 2015, 126 (23), pp.5379
Journal articles
hal-01290429v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma
Charlotte Fontan
,
Mourad Tiab
,
Pascal Godmer
,
Odile Luycx
,
Olivier Allangba
et al.
Journal articles
hal-01439375v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Management and outcome of primary CNS lymphoma in the modern era: An LOC network study
Caroline Houillier
,
Carole Soussain
,
Hervé Ghesquières
,
Pierre Soubeyran
,
Olivier Chinot
et al.
Journal articles
hal-02442415v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
Loic Ysebaert
,
Roch Houot
,
Ibrahim Yakoub-Agha
,
Franck Morschhauser
,
Charles Herbaux
et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles
hal-01290424v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Maroulio Pertesi
,
Maxime Vallée
,
Xiaomu Wei
,
Maria Revuelta
,
Perrine Galia
et al.
Journal articles
hal-02190723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study
Karim Labreche
,
Mailys Daniau
,
Amit Sud
,
Philip J Law
,
Louis Royer-Perron
et al.
Journal articles
hal-02328989v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|